Form 4: Lexicon Pharmaceuticals Executive Brian Crum Reports Stock Transactions

Brian Crum, SVP, General Counsel & Secretary of Lexicon Pharmaceuticals, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.

Summary

• On February 28, 2025, Brian T. Crum, SVP, General Counsel & Secretary of Lexicon Pharmaceuticals, exercised restricted stock units.
• These transactions involved the vesting of 26,097, 33,456, and 69,387 restricted stock units, each representing a contingent right to receive one share of common stock.
• Following the vesting, shares were withheld by the company to satisfy tax obligations, with 45,622 shares withheld at a price of $0.67.
• After these transactions, Crum directly owns 260,815 shares of Lexicon Pharmaceuticals common stock.
• Crum also directly owns 0, 33,457, and 138,773 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine filing related to stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the issuance and subsequent withholding of shares for tax purposes.

Key Dates